Literature DB >> 11726516

Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha.

G Xiao1, M E Cvijic, A Fong, E W Harhaj, M T Uhlik, M Waterfield, S C Sun.   

Abstract

IkappaB kinase (IKK) is a key mediator of NF-kappaB activation induced by various immunological signals. In T cells and most other cell types, the primary target of IKK is a labile inhibitor of NF-kappaB, IkappaBalpha, which is responsible for the canonical NF-kappaB activation. Here, we show that in T cells infected with the human T-cell leukemia virus (HTLV), IKKalpha is targeted to a novel signaling pathway that mediates processing of the nfkappab2 precursor protein p100, resulting in active production of the NF-kappaB subunit, p52. This pathogenic action is mediated by the HTLV-encoded oncoprotein Tax, which appears to act by physically recruiting IKKalpha to p100, triggering phosphorylation-dependent ubiquitylation and processing of p100. These findings suggest a novel mechanism by which Tax modulates the NF-kappaB signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11726516      PMCID: PMC125766          DOI: 10.1093/emboj/20.23.6805

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  73 in total

1.  A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice.

Authors:  S Miyawaki; Y Nakamura; H Suzuka; M Koba; R Yasumizu; S Ikehara; Y Shibata
Journal:  Eur J Immunol       Date:  1994-02       Impact factor: 5.532

2.  Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation.

Authors:  H C Liou; W C Sha; M L Scott; D Baltimore
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

3.  Overproduction of NFKB2 (lyt-10) and c-Rel: a mechanism for HTLV-I Tax-mediated trans-activation via the NF-kappa B signalling pathway.

Authors:  J Lanoix; J Lacoste; N Pepin; N Rice; J Hiscott
Journal:  Oncogene       Date:  1994-03       Impact factor: 9.867

4.  Autoregulation of the NF-kappa B transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs.

Authors:  S C Sun; P A Ganchi; C Béraud; D W Ballard; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

5.  Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture.

Authors:  R Grassmann; S Berchtold; I Radant; M Alt; B Fleckenstein; J G Sodroski; W A Haseltine; U Ramstedt
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

6.  p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction.

Authors:  F Mercurio; J A DiDonato; C Rosette; M Karin
Journal:  Genes Dev       Date:  1993-04       Impact factor: 11.361

7.  NF-kappaB-inducing kinase and IkappaB kinase participate in human T-cell leukemia virus I Tax-mediated NF-kappaB activation.

Authors:  M Uhlik; L Good; G Xiao; E W Harhaj; E Zandi; M Karin; S C Sun
Journal:  J Biol Chem       Date:  1998-08-14       Impact factor: 5.157

8.  The precursor of NF-kappa B p50 has I kappa B-like functions.

Authors:  N R Rice; M L MacKichan; A Israël
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

9.  Human T-cell leukemia virus type I Tax associates with and is negatively regulated by the NF-kappa B2 p100 gene product: implications for viral latency.

Authors:  C Béraud; S C Sun; P Ganchi; D W Ballard; W C Greene
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

10.  I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.

Authors:  P A Ganchi; S C Sun; W C Greene; D W Ballard
Journal:  Mol Biol Cell       Date:  1992-12       Impact factor: 4.138

View more
  115 in total

Review 1.  Host-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection.

Authors:  C M Tato; C A Hunter
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

2.  Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism.

Authors:  Benjamin Mordmüller; Daniel Krappmann; Meral Esen; Elmar Wegener; Claus Scheidereit
Journal:  EMBO Rep       Date:  2003-01       Impact factor: 8.807

Review 3.  NF-κB as a target for oncogenic viruses.

Authors:  Shao-Cong Sun; Ethel Cesarman
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

4.  Inhibition of immune activation by a novel nuclear factor-kappa B inhibitor in HTLV-I-associated neurologic disease.

Authors:  Unsong Oh; Matthew J McCormick; Dibyadeep Datta; Richard V Turner; Kathryn Bobb; Dileep D Monie; D Robert Sliskovic; Yuetsu Tanaka; Jie Zhang; Jeffrey Meshulam; Steven Jacobson
Journal:  Blood       Date:  2011-01-06       Impact factor: 22.113

5.  Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation.

Authors:  Bahram Razani; Brian Zarnegar; A Jimmy Ytterberg; Travis Shiba; Paul W Dempsey; Carl F Ware; Joseph A Loo; Genhong Cheng
Journal:  Sci Signal       Date:  2010-05-25       Impact factor: 8.192

6.  Endoproteolytic processing of C-terminally truncated NF-kappaB2 precursors at kappaB-containing promoters.

Authors:  Guoliang Qing; Zhaoxia Qu; Gutian Xiao
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-15       Impact factor: 11.205

7.  Lymphotoxin-alpha 1 beta 2 and LIGHT induce classical and noncanonical NF-kappa B-dependent proinflammatory gene expression in vascular endothelial cells.

Authors:  Lisa A Madge; Martin S Kluger; Jordan S Orange; Michael J May
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

8.  Cooperation of NF-kappaB2/p100 activation and the PDZ domain binding motif signal in human T-cell leukemia virus type 1 (HTLV-1) Tax1 but not HTLV-2 Tax2 is crucial for interleukin-2-independent growth transformation of a T-cell line.

Authors:  Masaya Higuchi; Chikako Tsubata; Rie Kondo; Sakiko Yoshida; Masahiko Takahashi; Masayasu Oie; Yuetsu Tanaka; Renaud Mahieux; Masao Matsuoka; Masahiro Fujii
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

Review 9.  Strategies of oncogenic microbes to deal with WW domain-containing oxidoreductase.

Authors:  Yao Chang; Yu-Yan Lan; Jenn-Ren Hsiao; Nan-Shan Chang
Journal:  Exp Biol Med (Maywood)       Date:  2014-12-07

10.  CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappaB subunits on IL-8 and Bcl-xL gene promoters.

Authors:  Barbara Marinari; Antonio Costanzo; Valeria Marzano; Enza Piccolella; Loretta Tuosto
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.